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Previewsphagosomes fuse with lysosomes within
20 min. Therefore, at least three mecha-
nisms influence TLR ligand containing
antigen maintenance in maturing DCs
at the level of lysosomes. TFEB regu-
lates lysosomal content, LC3 prevents
phagosome fusion with lysosomes and
Rab34 sequesters lysosomes for delayed
fusion with phagosomes, shortly after DC
maturation.
Altogether, the above discussed recent
studies, including the work by Alloatti and
colleagues in this issue of Immunity, have
given us several mechanisms (NOX2,
Rab34, TFEB, and LC3) by which DCs
regulate endocytosed antigen mainte-
nance. A picture is emerging by which
immature DCs cross-present, while
mature DCs upregulate this pathway tran-
siently during the first 20 hr after TLR
ligand exposure and then down-modulate
it. It now needs to be clarified whether all
of these mechanisms are operational at
the same time in the same DC subset,
particularly the proposed professional1030 Immunity 43, December 15, 2015 ª201cross-presenters, the XCR1+ DCs. More-
over we need to determine whether we
can harness the gained knowledge to
render cross-presentation more efficient
during vaccination, where its ability to
prime protective T cell responses has
lagged behind classical antigen process-
ing for MHC class I presentation from re-
combinant viral vectors. Thus, keeping
phagosomes and lysosomes apart might
allow endocytosed antigen, particularly
vaccine formulations, to boldly go where
no one has gone before, namely to
highly efficient cross-presentation on
MHC class I molecules.REFERENCES
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Tissue-residentmemory T (Trm) cells patrol barrier tissues. In this issue of Immunity, Carbone and colleagues
show that downregulation of T-box proteins Eomesodermin and T-bet is critical for their differentiation, but
residual levels of T-bet are important for long-term Trm survival and function.During acute viral infections, virus-spe-
cific CD8+ T cell expansion is coupled
to differentiation pathways resulting in
both effector andmemory T cells. Effector
T cells control the infection but are not
long-lived, whereas memory T cells sur-
vive after the infection, are self-sustaining,
and provide life-long immunity. Extensive
work from many labs has identified pat-
terns of transcription-factor expression
that instruct the development of memory
or effector T cells. For the most part, tran-
scription factors that drive fate decisionsare expressed dichotomously: cells that
have a short half-life express one pattern
and those that will develop into self-sus-
taining memory populations express the
opposite (comprehensively reviewed in
Kaech and Cui, 2012). Perhaps the best
studied of these transcription factors
are the T-box family proteins T-bet and
Eomesodermin (Eomes). High levels of
T-bet are well known to promote effector
differentiation and inhibit memory for-
mation. In contrast, Eomes promotes
memory formation and is critical for thedevelopment and persistence of memory
CD8+ T cell populations. The elegant yin
and yang of this model explains the
formation of long-lived and short-lived
T cells—at least for those T cells found
in circulation and lymphoid tissues after
infection.
It has become apparent in recent years
that circulating and lymphoid-localized
memory T cells comprise only a fraction
of the T cell memory elicited by infections
(Schenkel and Masopust, 2014; Steinert























Figure 1. Schematic Depicting the Expression of T-bet and Eomes during the Differentiation
of Memory T Cells
For circulating and lymphoid-localized T cells, the progression from effector to memory T cells is coupled
to an increase in the expression of Eomes and a downregulation of T-bet (top). In contrast, for tissue-
localized Trm cells, Carbone and colleagues show that development of a self-sustaining memory popu-
lation depends on TGF-b driving a loss of Eomes from the cells, as well as the downregulation of T-bet
(bottom) (Mackay et al., 2015). Importantly, residual T-bet expression in Trm cells is required for
expression of both the IL-15R, which is critical for Trm cell survival, and IFN-g, which is important for Trm
cell function.
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PreviewsIndeed, a substantial number of memory
T cells are found in non-lymphoid tis-
sues, and these T cells can be true resi-
dents of the tissues they inhabit. These
so-called tissue-resident memory T (Trm)
cells have been largely defined by co-
expression of the molecules CD69 and
CD103 and are particularly evident in bar-
rier tissues where they are described to (1)
persist with a peri- or intra-epithelial local-
ization, (2) participate in the control of
local cognate infections, and (3) promote
the recruitment of new immune cells to
the area in an interferon-g (IFN-g)-depen-
dent manner (Schenkel and Masopust,
2014). Importantly, these Trm cells are
not simply circulating memory cells that
have migrated into tissue during or after
infection and gotten stuck. Rather, Trm
cells appear to represent an independent
memory T cell lineage—the product of a
distinct differentiation pathway that en-
ables their migration to, and retention
within, tissues (Mackay et al., 2013;
Skon et al., 2013). In short, Trm cells
develop specifically, and persist on the
front lines where they can provide on-
site and immediate memory of previous
infections.
As we have begun to understand the
potential for these cells to impact immuneresponses, there has been great interest
in understanding how, when, and where
they are formed. Mechanistically, how-
ever, our understanding of Trm cell devel-
opment has been somewhat limited.
Recent work showed that T-bet is
downregulated in lung-localized Trm cells
that were formed after acute influenza
infection (Laidlaw et al., 2014). Moreover,
forcing T-bet expression in this system
antagonized Trm cell formation in the
lung, whereas reducing T-bet expression
had the opposite effect and enhanced
Trm cell development. These results fit
well with the previously described role
for T-bet in promoting effector cells and
antagonizing the development of long-
lived memory populations. One might
have predicted, then, that Trm cells
would maintain elevated expression of
the memory-promoting transcription
factor Eomes, just like circulating and
lymphoid-localized memory T cells (Fig-
ure 1). However, in this issue of Immunity,
Carbone and colleagues demonstrate
that Trm cells don’t follow these rules
(Mackay et al., 2015). Whereas T-bet
was downregulated within skin Trm
cells induced by herpes simplex virus-1
(HSV-1) infection, Eomes expression
was completely lost (Figure 1). Moreover,Immunity 43, Deforced expression of either T-bet or
Eomes greatly inhibited the formation
or retention of Trm cells, demonstrating
that downregulation of both T-box tran-
scription factors is a critical step in Trm
cell development. Thus, long-lived, self-
sustaining Trm cells in the skin expressed
a low-level of T-bet like other memory
T cells but, surprisingly, no Eomes.
Having established that downregula-
tion of T-bet and Eomes was important
for Trm cell formation, Carbone and col-
leagues performed a series of elegantly
simple experiments to define the control
of these T-box transcription factors and
their role in Trm cell formation and
survival. It is now well accepted that
transforming growth factor b (TGF-b)
signaling is critical for the differentiation
and retention of Trm cells (Zhang and
Bevan, 2013). TGF-b signaling has been
shown to induce expression of the aE in-
tegrin CD103 (Casey et al., 2012), which
is important for Trm cell retention in the
skin (Mackay et al., 2013). TGF-b also
suppresses the transcription factor
KLF2, which results in the downregulation
of the sphingosine-1-phosphate receptor
(S1P1) (Skon et al., 2013) and enables
T cells to ignore the S1P signals that
would lead them out of the tissue. In the
current study, Carbone and colleagues
found that TGF-b signaling also reduced
T-bet and Eomes expression, enabling
Trm cell development (Mackay et al.,
2015). Strikingly, forced expression of
T-bet or Eomes reduced the expression
of the TGF-b receptor on T cells and pre-
vented TGF-b from promoting CD103
expression. These data begin to explain
why forced expression of T-bet and
Eomes limit Trm cell formation. Moreover,
they suggest that TGF-b signals can
enhance TGF-b responsiveness in the
cell by reducing expression of T-bet
and Eomes—a system that the authors
describe as ‘‘feedforward.’’
Because T-bet antagonizes the devel-
opment of memory-precursor cells, which
are also the precursors of Trm cells
(Mackay et al., 2013), and a reduction of
T-bet promoted Trm cell development in
this and previous work (Laidlaw et al.,
2014; Mackay et al., 2015), the authors
hypothesized that an absence of T-bet
would enable even more Trm cell forma-
tion. At first, this appeared to be true
because T-bet-deficient Trm cells were
found at elevated numbers within thecember 15, 2015 ª2015 Elsevier Inc. 1031
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Previewsskin 7 days after infection. However, just
1 week later, these cells were nearly all
gone, indicating that a loss of T-bet
enhanced Trm cell formation but pre-
vented their survival. Both T-bet and
Eomes can promote the expression of
the interleukin-15 (IL-15) receptor, which
had been previously shown by this group
to be important for Trm cell formation or
survival (Mackay et al., 2013). Thus,
because Eomes was lost during Trm cell
development, the authors hypothesized
that residual T-bet was critical for main-
taining the IL-15 receptor. Indeed, skin-
localized T cells lacking T-bet still lost
Eomes expression as they differentiated
into CD103+ Trm cells, and this corre-
sponded with a loss of the IL-15 receptor
and loss of cells from the skin. Impor-
tantly, blockade of IL-15 more than
30 days after infection, which is well after
Trm cells had been formed, resulted in a
loss of CD103+ Trm cells from the tissue,
but had no effect on CD103 T cells in
the same tissue. These data point to
IL-15 as a critical survival factor for fully
differentiated (i.e., Eomesneg, T-betlow)
Trm cells. Collectively, these data suggest
that the loss of Eomes during Trm cell for-
mation forces the Trm cells to rely on
residual T-bet expression for mainte-
nance of the IL-15 receptor, and that this
process is orchestrated by TGF-b signals
early in Trm cell development. Interest-
ingly, the downregulation of Eomes in
T-bet-deficient T cells also left Trm cells
incapable of secreting IFN-g, which is
important for the recruitment of new cells
into the tissue and the activation of innate
immune defenses in the local area upon
challenge (Schenkel and Masopust,
2014). Thus, although downregulation of
T-bet and Eomes is critical to allow1032 Immunity 43, December 15, 2015 ª201TGF-b to promote Trm cell formation,
some level of residual T-bet expression
is needed to enable both the survival (via
IL-15 receptor) and function (via IFN-g)
of Trm cells.
Overall, this study beautifully illustrates
an unexpected balance between TGF-b
signaling and the T-box transcription fac-
tors T-bet and Eomes. It will be interesting
to learn why Eomes is so completely lost
while T-bet is only reduced during Trm
cell differentiation and whether conditions
within the infected tissue can modulate
this outcome. Moreover, while this study
begins to illustrate how T-bet and Eomes
antagonize Trm cell development, the
transcriptional networks that promote
Trm cell differentiation still remain to be
elucidated. Previous work by this group
demonstrated that Trm cells upregu-
late a number of genes relative to their
circulating memory counterparts (Mackay
et al., 2013). How these genes fit into
known transcriptional networks and
which genes are essential for Trm cell
development and which are regulated by
TGF-bwill be interesting to learn. Interest-
ingly, the evidence suggests that Trm cell
formation is not governed by the same
rules in different tissues (Schenkel and
Masopust, 2014). Antigen is needed for
Trm cell formation in some but not other
sites. Likewise, CD103 expression is crit-
ical for Trm cell maintenance and localiza-
tion in some, but not other models. Thus,
determining which rules are universal and
which governed by context will ultimately
need to be addressed, and the answers
should be exciting. Finally, it’s worth
noting that Trm cells have been identified
in humans (Sathaliyawala et al., 2013).
However, it is still unclear how the
Trm cell pool will adapt and change in5 Elsevier Inc.response to the repeated pathogen in-
sults faced by people and whether these
cells can persist and remain effective for
decades of life and through old age.
In summary, Carbone and colleagues
have tied together several previous ob-
servations and added novel mechanistic
data to form an outstanding picture of
Trm cell development in the skin and a
strong basis for future study of Trm cell
formation, function, and survival.REFERENCES
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